Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Cell Reports|November 9, 2022
An epitope-enriched immunogen expands responses to a conserved viral siteTimothy M Caradonna, Larance Ronsard, Ashraf S Yousif, et al.
Cell|January 7, 2021
COVID-19-neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
COVID-19 neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD AntibodiesNicholas C Curtis, Seungmin Shin, Andrew P Hederman, et al.
Nature Medicine|November 8, 2016
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strainDonald D Raymond, Shaun M Stewart, Jiwon Lee, et al.
Immunity|August 14, 2020
Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalCaroline Atyeo, Stephanie Fischinger, Tomer Zohar, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
High-Throughput Antibody Neutralization Screening in Massively Parallel Droplet ArraysMatias Gutierrez-Gonzalez, Ahmed S Fahad, Cyrille L Delley, et al.
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
Immunity|April 26, 2024
Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A virusesRashmi Ray, Faez Amokrane Nait Mohamed, Daniel P Maurer, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Pageof 11